| Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma M Bai, B Zou, Z Wang, P Li, H Wang, Y Ou, K Cui, J Bian, S Li, X Xu International urology and nephrology 50, 1801-1809, 2018 | 25 | 2018 |
| TPPP3 promotes cell proliferation, invasion and tumor metastasis via STAT3/Twist1 pathway in non-small-cell lung carcinoma Y Li, M Bai, Y Xu, W Zhao, N Liu, J Yu Cellular Physiology and Biochemistry 50 (5), 2004-2016, 2018 | 20 | 2018 |
| PET/CT metabolic patterns in systemic immune activation: a new perspective on the assessment of immunotherapy response and efficacy P Jin, J Li, Y Meng, L Wu, M Bai, J Yu, X Meng Cancer Letters 520, 91-99, 2021 | 15 | 2021 |
| Efficacy of immune checkpoint inhibitors in patients with EGFR mutated NSCLC and potential risk factors associated with prognosis: a single institution experience M Bai, W Wang, X Gao, L Wu, P Jin, H Wu, J Yu, X Meng Frontiers in Immunology 13, 832419, 2022 | 13 | 2022 |
| Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and … L Wu, Z Zhang, M Bai, Y Yan, J Yu, Y Xu Cell Communication and Signaling 21 (1), 119, 2023 | 10 | 2023 |
| Integrated analysis of EGFR mutated non‐small cell lung cancer reveals two distinct molecular subtypes M Bai, L Wu, M Zhao, P Jin, J Liu, W Wang, X Gao, Y Wang, W Chong, ... Clinical and Translational Medicine 13 (10), 2023 | 2 | 2023 |
| Negative Correlation Between 18F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer L Wu, J Liu, S Wang, M Bai, M Wu, Z Gao, J Li, J Yu, J Liu, X Meng Frontiers in Endocrinology 13, 913631, 2022 | 2 | 2022 |
| PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation X Hu, M Zhao, M Bai, Z Xue, F Wang, Z Zhu, J Yu, J Yue Cancer Letters 586, 216676, 2024 | 1 | 2024 |
| Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced … P Jin, M Bai, J Liu, J Yu, X Meng Frontiers in Immunology 13, 1004351, 2022 | 1 | 2022 |
| Survival outcomes of targeted and immune consolidation therapies in locally advanced unresectable lung adenocarcinoma X Wang, X Meng, G Cai, P Jin, M Bai, Y Fu, Z Wang, J Guo, X Han International Immunopharmacology 129, 111684, 2024 | | 2024 |
| The Detection and Clinical Significance of Circulating Tumor Cells in Patients with Renal Cell Carcinoma H Wang, B Zou, S Li, M Bai Biomedical Journal of Scientific & Technical Research 38 (3), 30313-30323, 2021 | | 2021 |
| 肾癌循环肿瘤细胞检测及其临床意义的研究现状 白孟麟， 李胜， 夏梅 山东医药 57 (46), 103-106, 2017 | | 2017 |
| Integrated Analysis of EGFR Mutated NSCLC Reveals Two Distinct Molecular Subtypes M Bai, L Wu, P Jin, W Wang, X Gao, Y Wang, J Yu, H Chen, X Meng Available at SSRN 4329988, 0 | | |
